Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 07, 2016 07:00 ET | Source: MediWound Ltd.

MediWound’s NexoBrid® Receives Reimbursement in Italy

YAVNE, Israel, June 07, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
June 01, 2016 07:00 ET | Source: MediWound Ltd.

MediWound to Present at Jefferies 2016 Healthcare Conference

YAVNE, Israel, June 01, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
May 31, 2016 07:30 ET | Source: MediWound Ltd.

Data Published in Bone & Joint Research Supports MediWound’s Bromelain-Based Enzyme for the Release of Dupuytren’s Contracture

YAVNE, Israel, May 31, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
May 19, 2016 07:00 ET | Source: MediWound Ltd.

MediWound’s NexoBrid® Highlighted in “Best Oral Presentation” at the British Burn Association 49th Annual Conference and Scientific Meeting

YAVNE, Israel, May 19, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
May 02, 2016 07:00 ET | Source: MediWound Ltd.

MediWound’s NexoBrid® to be Highlighted in Presentations at the American Burn Association 48th Annual Meeting

YAVNE, Israel, May 02, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
April 26, 2016 07:00 ET | Source: MediWound Ltd.

MediWound’s NexoBrid to be Available in Japan through Kaken Pharmaceuticals Co., Ltd.

YAVNE, Israel, April 26, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
April 21, 2016 07:00 ET | Source: MediWound Ltd.

MediWound Reports First Quarter 2016 Financial Results

YAVNE, Israel, April 21, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
April 14, 2016 07:00 ET | Source: MediWound Ltd.

MediWound to Host First Quarter 2016 Financial Results Conference Call on April 21, 2016 at 8:30 a.m. Eastern Time

YAVNE, Israel, April 14, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn...
April 08, 2016 07:00 ET | Source: MediWound Ltd.

Top-Line Results from Phase 2 Study with MediWound’s EscharEx to Treat Chronic Wounds Will be Presented at the Symposium on Advanced Wound Care Spring 2016

YAVNE, Israel, April 08, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
April 06, 2016 07:00 ET | Source: MediWound Ltd.

MediWound to Present at Needham & Company’s 15th Annual Healthcare Conference

YAVNE, Israel, April 06, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn...